Metro Health, Michigan
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Metro Health, Michigan sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,751 sponsors by registered trial count).
Metro Health, Michigan: 4 sponsored US clinical trials, none currently recruiting.
Metro Health, Michigan sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 1 trials.
Upper-quartile sponsor footprint
Metro Health, Michigan sits in the upper quartile of the sponsor corpus (#2,913 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
The Impact of Low Pressure Pneumo in RARP
NCT03370016
Chlorhexidine Gluconate Versus Povidone-Iodine as Vaginal Preparation Antiseptics Prior to Cesarean Delivery
NCT03133312
A Study to Determine the Effectiveness of Utilizing Intraperitoneal Bupivacaine
NCT03004222
Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"
NCT02786173
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Therapeutic Areas
How the Metro Health, Michigan archive is shaped
4 indexed studies, none listed as recruiting (0% open); 4 completed (100%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Prostate Cancer (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.